| Product Name | MF | CAS | Details |
|---|
| 9H-Carbazole-3,6-dicarbonitrile | C14H7N3 | 57103-03-4 | Details |
| 2-[(Methylsulfamoyl)amino]acetic acid | C3H8N2O4S | 1593743-89-5 | Details |
| (E)-3-Tricyclo[3.3.1.13,7]dec-1-yl-2-propenoic acid | C13H18O2 | 136258-27-0 | Details |
| 4-Bromo-2,7-naphthyridin-1(2H)-one | C8H5BrN2O | 959558-27-1 | Details |
| NSC 624206 | C19H33Cl2NS2 | 13116-77-3 | Details |
| {4-[(2-Aminophenyl)sulfanyl]butyl}phosphonic acid | C10H16NO3PS | 191411-61-7 | Details |
| 2,2,2-Trifluoroacetamide | C2H2F3NO | 354-38-1 | Details |
| Belvarafenib | C23H16ClFN6OS | 1446113-23-0 | Details |
| Ac-IEGR-OH | Details |
| RPH3A antibody (ser234) | Details |
| 2-[Methyl[(nonafluorobutyl)sulphonyl]amino]ethyl acrylate | C10H10F9NO4S | 67584-55-8 | Details |
| Fmoc-Val-Cit-PAB-MMAE | C73H104N10O14 | 1350456-56-2 | Details |
| (R)-(+)-Limonene | C10H16 | 5989-27-5 | Details |
| Rutacridone | C19H17NO3 | 17948-33-3 | Details |
| 4-Chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine | C7H6ClN3 | 7781-10-4 | Details |
| 1-Benzyl-3-bromo-1H-indazole | C14H11BrN2 | 29985-03-3 | Details |
| (1S,2S,4S)-Bicyclo[2.2.1]heptan-2-amine hydrochloride | C7H14ClN | 121122-83-6 | Details |
| Butyl(2-methoxyethyl)amine | C7H17NO | 58203-00-2 | Details |
| 6-Benzyl-6-azabicyclo[3.2.1]octane-2,7-dione | C14H15NO2 | 1801983-04-9 | Details |
| CK1 gamma 2 Blocking Peptide | Details |
| Biot-EADPTGHSY-OH | Details |
| 2-(Propane-1-sulfonyl)acetonitrile | C5H9NO2S | 175137-61-8 | Details |
| (7Alpha,17Alpha)- 9,17-Dihydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic acid di-gamma-lactone | C23H28O5 | 209253-67-8 | Details |
| 2-Thiopheneethanol tosylate | C13H14O3S2 | 40412-06-4 | Details |
| 5-[(2-Fluorophenyl)methyl]-1,2,4-oxadiazole-3-carboxylic acid | C10H7FN2O3 | 1339354-36-7 | Details |
| 5-?Imino-?10H-?phenothiazine 5-?oxide hydrochloride | C12H11ClN2OS | 2137936-69-5 | Details |
| 1-(2,2-Difluoroethyl)-3-methyl-1H-pyrazole | C6H8F2N2 | 1171013-54-9 | Details |
| 6a-Hydroxy budesonide | C25H34O7 | 577777-51-6 | Details |
| LANCL3 antibody | Details |
| N4-Benzoyl-5'-O-DMT-2'-O-methyl-5-methylcytidine | C39H39N3O8 | 741725-57-5 | Details |
| Belinostat amide | C15H14N2O3S | 1485081-57-9 | Details |
| 1-Ethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride | C11H16ClN | 103861-49-0 | Details |
| 1-[5-(4-Chlorophenyl)-2-thienyl]-1-ethanone | C12H9ClOS | 51335-90-1 | Details |
| C20ORF116 antibody | Details |
| Lys27(Azido), Exendin-4 | Details |
| Imidazo[1,2-a]pyrimidin-2-amine | C6H6N4 | 301331-27-1 | Details |
| H-LGLLLHDSIQIPR^-OH | Details |
| 3-Methylpiperidine-2,6-dione | C6H9NO2 | 29553-51-3 | Details |
| 5-Bromo-3-fluoro-2-hydroxybenzoic acid | C7H4BrFO3 | 251300-29-5 | Details |
| TRIM63 antibody | Details |
| Octyl 4-methoxycinnamate | C18H26O3 | 5466-77-3 | Details |
| AquaSpark??beta-D-galactoside, 10 mM in DMSO, Ramot at Tel-Aviv University Ltd. Patent family WO 2017/130191 | C34H39ClO12 | 2390553-19-0 | Details |
| N6-Benzoyl-2'-deoxy-5'-O-DMT-adenosine 3'-thiophosphoramidite | Details |
| Emtricitabine impurity 9 | C10H20O | 20752-33-4 | Details |
| 2,3-Dichloro-4-fluorobenzaldehyde | C7H3Cl2FO | 845907-07-5 | Details |
| Methyl 4-amino-2,2-dimethyloxane-4-carboxylate | C9H17NO3 | 55795-83-0 | Details |
| 4'-C-Azido-2'-deoxy-2'-fluoro-β-D-arabinocytidine | C9H11FN6O4 | 1011529-10-4 | Details |
| 2-(2,6-Dimethylpiperidin-1-yl)-2-oxoacetic acid | C9H15NO3 | 768329-98-2 | Details |
| 1-(Hydroxymethyl)cyclohexane-1-carbonitrile | C8H13NO | 50654-43-8 | Details |
| rac N,O-didesmethyl venlafaxine b-D-glucuronide hydrochloride | C21H31NO8 | 1021933-99-2 | Details |
| 2-bromo-5-chloropyridine-3-carbaldehyde | C6H3BrClNO | 1227605-52-8 | Details |
| Thiamet G | C9H16N2O4S | 1009816-48-1 | Details |
| N-Ethylpiperidine-3-carboxamide | C8H16N2O | 4138-28-7 | Details |
| 3-Amino-3-cyclopentylpropan-1-ol | C8H17NO | 790227-23-5 | Details |
| 1-Bromo-3-(2-chloroethanesulfonyl)benzene | C8H8BrClO2S | 1341100-35-3 | Details |
| tert-Butyl N-[(5,6-dimethylpiperidin-2-yl)methyl]carbamate | C13H26N2O2 | 1934550-27-2 | Details |
| 1-(4-Methoxyphenyl)-2,2-dimethylpropan-1-one | C12H16O2 | 2040-26-8 | Details |
| o-Cresol-d7 | C7HD7O | 202325-50-6 | Details |
| Sophoridine | C15H24N2O | 6882-68-4 | Details |
| 1-[2-(tert-Butoxy)-2-oxoethyl]-1H-1,2,3-triazole-4-carboxylic acid | C9H13N3O4 | 2060044-01-9 | Details |
| 6-Chloroimidazo[2,1-b]thiazole-5-sulfonyl chloride | C5H2Cl2N2O2S2 | 150020-64-7 | Details |
| 3-Amino-2-[(3-fluorophenyl)methyl]-1-(morpholin-4-yl)propan-1-one hydrochloride | C14H20ClFN2O2 | 1795486-28-0 | Details |
| 3-[4-(1-Aminoethyl)phenyl]-1-phenylurea | C15H17N3O | 954568-55-9 | Details |
| 2-Nitrophenyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | C20H24N2O11 | 13089-26-4 | Details |
| 6-(3-Chlorophenyl)-4-[(4-methoxyphenyl)methyl]morpholin-3-one | C18H18ClNO3 | 1803584-60-2 | Details |
| N-[2-(4'-Chlorophenylacetonitrile)]-2,3,4,6-tetra-pivaloyl-D-glucopyranoside | C45H94N+ | 71843-89-5 | Details |
| FAS antibody (Tyr291) | Details |
| 5-Oxo-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-carboxylic acid | C12H12O3 | 3470-47-1 | Details |
| 3-(Benzyloxy)-2-methylpropan-1-amine | C11H17NO | 114377-41-2 | Details |
| 5-Iodo-2-phenylpyridine | C11H8IN | 1214342-99-0 | Details |
| H-L-Lys(lactoyl)-OH | C9H18N2O4 | 928122-01-4 | Details |
| 2-Fluoro-6-(1H-pyrazol-1-yl)benzoic acid | C10H7FN2O2 | 1521055-55-9 | Details |
| 4-(Pyrazin-2-yl)benzoic acid | C11H8N2O2 | 216060-23-0 | Details |
| 4-[2-(Pyridin-3-yl)acetamido]benzoic acid | C14H12N2O3 | 1480111-47-4 | Details |
| Methyl N-(cyanomethyl)-N-cyclopropylcarbamate | C7H10N2O2 | 1251922-57-2 | Details |
| Benzyl-(6-methyl-pyridin-2-ylmethyl)-amine | C14H16N2 | 101938-10-7 | Details |
| PSME3 Blocking Peptide | Details |
| 4-(Oxetan-3-yloxy)piperidine hydrochloride | C8H16ClNO2 | 2138379-43-6 | Details |
| 4-(Bromomethyl)-3-chloropyridine hydrobromide | C6H6Br2ClN | 1256562-25-0 | Details |
| 5-(3-Chlorophenyl)-4-(furan-2-ylmethyl)-4H-1,2,4-triazole-3-thiol | C13H10ClN3OS | 893725-06-9 | Details |
| Nbr1 antibody | Details |
| Synaptoporin antibody | Details |
| 2-(2-Methoxyphenyl)-2-methylcyclopropan-1-amine hydrochloride | C11H16ClNO | 1354954-14-5 | Details |
| 1-Methyl-2,3-dihydro-1H-indol-6-ylamine dihydrochloride | C9H14Cl2N2 | 1414958-31-8 | Details |
| Cytokeratin 19 antibody | Details |
| Transferrin antibody (HRP) | Details |
| (2E)-3-(1-Phenyl-1H-pyrazol-4-yl)prop-2-enoic acid | C12H10N2O2 | 27268-04-8 | Details |
| S100B antibody (biotin) | Details |
| TCR beta antibody (biotin) | Details |
| 1-Ethyl-3-isocyanobenzene | C9H9N | 1610952-40-3 | Details |
| 1-Fluoro-3-methoxy-5-nitrobenzene | C7H6FNO3 | 7087-60-7 | Details |
| Human IgG3 (hinge) Heavy Tryptic Peptide Standard (4nmol) | Details |
| (R)-1-(Thiazol-2-yl)ethanamine dihydrochloride | C5H8N2S | 623143-43-1 | Details |
| Recombinant Rat IL-17AF | Details |
| N-(4H-1,2,4-Triazol-3-yl)pyridin-3-amine | C7H7N5 | 1803588-42-2 | Details |
| cis-Nerolidol | C15H26O | 3790-78-1 | Details |
| 2-Methoxy-3-(1H-1,2,3,4-tetrazol-5-yl)pyridine | C7H7N5O | 13599-95-6 | Details |
| Ethyl 1-aminospiro[2.5]octane-1-carboxylate hydrochloride | C11H19NO2.ClH | 2305256-07-7 | Details |
| H-VVLEGGIDPILR-OH | Details |
| CYP20A1 antibody | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||